FDA Inspection 1037735 — Central Pennsylvania Blood Bank

Central Pennsylvania Blood Bank — FEI 1000307044

The FDA completed an inspection of Central Pennsylvania Blood Bank on December 5, 2017 in Harrisburg, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 5, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Harrisburg, PA (United States)